BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 23108541)

  • 21. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells.
    Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z
    Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sperm Release From the Oviductal Epithelium Depends on Ca(2+) Influx Upon Activation of CB1 and TRPV1 by Anandamide.
    Gervasi MG; Osycka-Salut C; Sanchez T; Alonso CA; Llados C; Castellano L; Franchi AM; Villalón M; Perez-Martinez S
    J Cell Biochem; 2016 Feb; 117(2):320-33. PubMed ID: 26129689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticonvulsive effects of endocannabinoids; an investigation to determine the role of regulatory components of endocannabinoid metabolism in the Pentylenetetrazol induced tonic- clonic seizures.
    Zareie P; Sadegh M; Palizvan MR; Moradi-Chameh H
    Metab Brain Dis; 2018 Jun; 33(3):939-948. PubMed ID: 29504066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
    Romero TR; Pacheco Dda F; Duarte ID
    Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
    Desroches J; Charron S; Bouchard JF; Beaulieu P
    Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An introduction to the endocannabinoid system: from the early to the latest concepts.
    De Petrocellis L; Di Marzo V
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors.
    Steiner AA; Molchanova AY; Dogan MD; Patel S; Pétervári E; Balaskó M; Wanner SP; Eales J; Oliveira DL; Gavva NR; Almeida MC; Székely M; Romanovsky AA
    J Physiol; 2011 May; 589(Pt 9):2415-31. PubMed ID: 21486787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocannabinoid-mediated retrograde modulation of synaptic transmission.
    Ohno-Shosaku T; Kano M
    Curr Opin Neurobiol; 2014 Dec; 29():1-8. PubMed ID: 24747340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of the endocannabinoid system in periodontal healing.
    Kozono S; Matsuyama T; Biwasa KK; Kawahara K; Nakajima Y; Yoshimoto T; Yonamine Y; Kadomatsu H; Tancharoen S; Hashiguchi T; Noguchi K; Maruyama I
    Biochem Biophys Res Commun; 2010 Apr; 394(4):928-33. PubMed ID: 20233580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The rise and fall of anandamide: processes that control synthesis, degradation, and storage.
    Biringer RG
    Mol Cell Biochem; 2021 Jul; 476(7):2753-2775. PubMed ID: 33713246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
    Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
    J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.
    Rossi F; Siniscalco D; Luongo L; De Petrocellis L; Bellini G; Petrosino S; Torella M; Santoro C; Nobili B; Perrotta S; Di Marzo V; Maione S
    Bone; 2009 Mar; 44(3):476-84. PubMed ID: 19059369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
    Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
    Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors.
    Nader J; Rapino C; Gennequin B; Chavant F; Francheteau M; Makriyannis A; Duranti A; Maccarrone M; Solinas M; Thiriet N
    Neuropharmacology; 2014 Dec; 87():214-21. PubMed ID: 24709540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of NMDAR and NMDAR-mediated metaplasticity by anandamide and 2-AG in the hippocampus.
    Yang K; Lei G; Xie YF; MacDonald JF; Jackson MF
    Hippocampus; 2014 Dec; 24(12):1601-14. PubMed ID: 25087967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A putative 'pre-nervous' endocannabinoid system in early echinoderm development.
    Buznikov GA; Nikitina LA; Bezuglov VV; Francisco ME; Boysen G; Obispo-Peak IN; Peterson RE; Weiss ER; Schuel H; Temple BR; Morrow AL; Lauder JM
    Dev Neurosci; 2010 Mar; 32(1):1-18. PubMed ID: 19907129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats.
    Lobato NS; Filgueira FP; Prakash R; Giachini FR; Ergul A; Carvalho MH; Webb RC; Tostes RC; Fortes ZB
    PLoS One; 2013; 8(5):e63449. PubMed ID: 23667622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
    Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
    Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.